Cromos Pharma, where the patients are

AstraZeneca

Cancer Research U.K. to launch 14-drug, personalized medicine trial

Friday, April 18, 2014 01:57 PM

British researchers, working with two global pharmaceutical companies, are planning to launch a different kind of personalized medicine clinical trial that could change how cancer drugs are studied and potentially cut the time and cost of bringing them to market.

More... »

CRF Health eCOA webinar series

Icon’s Firecrest training recognized by TransCelerate BioPharma

Monday, April 14, 2014 10:13 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that its Firecrest training meets TransCelerate BioPharma’s minimum criteria for International Conference on Harmonization Good Clinical Practice (ICH/GCP) training.

More... »


CEO Roundtable on Cancer launches data-sharing initiative to accelerate drug development

Thursday, April 10, 2014 01:03 PM

The CEO Roundtable on Cancer has launched Project Data Sphere, a new online oncology data-sharing platform using de-identified cancer patient information with the goal of accelerating drug discovery—by developing more efficient clinical trial protocols, epidemiological studies and, ultimately, new cancer therapies. 

More... »

Glythera makes appointments to support company expansion

Thursday, April 3, 2014 11:26 AM

Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and stable glycan technologies PermaLink and PermaCarb, has appointed of Nigel Burns as non-executive director and Ian Evetts as commercial director. Glythera has recently validated data from their core technologies and the addition of Burns and Evetts coincides with the company’s expansion plan exploring new opportunities to provide essential support during the company’s growth plan.

More... »

AstraZeneca, Shenzhen University Health Science Center to collaborate

Monday, March 31, 2014 01:37 PM

AstraZeneca has announced a research collaboration with Shenzhen University Health Science Center. The partners will undertake preclinical research focused on chronic kidney disease (CKD), which represents a large and growing unmet medical need in China.

More... »

AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.

Wednesday, March 26, 2014 11:40 AM

AstraZeneca has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. The purchase was valued at approximately $102 million and gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.

More... »

MD Anderson, MedImmune collaborate on cancer immunotherapy

Monday, March 17, 2014 01:42 PM

The University of TexasMD Anderson Cancer Center and MedImmune, the global biologics R&D arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

More... »

AstraZeneca sells Alderley Park site in Cheshire, U.K.

Wednesday, March 12, 2014 01:41 PM

AstraZeneca has sold its Alderley Park site in Cheshire, U.K., to Manchester Science Parks(MSP), a Greater Manchester-based public-private partnership and science park operator.

More... »

AstraZeneca, Korea Health Industry Development Institute partner

Monday, March 10, 2014 11:53 AM

AstraZeneca has signed a memorandum of understanding (MOU) with the Korea Health Industry Development Institute (KHIDI), a government-funded institution aiming to enhance global competitiveness of the healthcare industry, to establish an Oncology Research Program.

More... »

AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge

Monday, February 24, 2014 11:38 AM

AstraZeneca has entered into a collaboration with the Cancer Research U.K. (CRUK) Cambridge Institute to temporarily locate up to 60 AstraZeneca scientists in the Institute.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs